Scott & Selber Inc’s Elevance Health ELV Stock Holding History

Scott & Selber Inc’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,230	Closed	-$1.9M	–	75
2018 Q4	$1.9M	Buy	+7,230	New	+$1.99M	1.16%	39

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Scott & Selber Inc's ELV Position: Q1 2019 in Review

Scott & Selber Inc sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 7,230 shares — an estimated $1.9M sold.

Scott & Selber Inc first reported a position in ELV in Q4 2018 and held it in 1 quarter. The position peaked at $1.9M in Q4 2018. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

Scott & Selber Inc reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
Scott & Selber Inc sold 7,230 Elevance Health shares in Q1 2019, an estimated $1.9M.
Scott & Selber Inc first reported a position in Elevance Health in Q4 2018 and held it in 1 quarter.
Scott & Selber Inc's Elevance Health position peaked at $1.9M in Q4 2018.
1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Scott & Selber Inc's 13F filing for Q1 2019, filed 3 May 2019.